Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report

Inflamm Bowel Dis. 2022 Jan 5;28(1):e1-e2. doi: 10.1093/ibd/izab196.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Colitis, Ulcerative* / drug therapy
  • Dasatinib / adverse effects
  • Humans
  • Imatinib Mesylate / adverse effects
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Pyrimidines / adverse effects

Substances

  • Pyrimidines
  • Imatinib Mesylate
  • Dasatinib